Open access · CC-BY
via OpenAlex
Mechanistic Insights into Anti-Melanogenic Effects of Fisetin: PKCα-Induced β-Catenin Degradation, ERK/MITF Inhibition, and Direct Tyrosinase Suppression
Zin Zin, Satapat Racha, Hongbin Zou, Pithi Chanvorachote B
International Journal of Molecular Sciences · 2025 · ▲ 4 citations
Abstract
Excessive melanin production causes hyperpigmentation disorders such as freckles, melasma, and age spots, affecting appearance and quality of life. Tyrosinase is the key enzyme controlling melanin synthesis, and natural compounds are being explored as effective tyrosinase inhibitors. Fisetin, a dietary flavonoid found in fruits and vegetables like grapes and onions, is known for its anti-inflammatory and anticancer properties, but its anti-melanogenic activity remains unclear. This study demonstrated that fisetin, up to 60 μM, is non-toxic and significantly decreases tyrosinase activity and melanin content in human melanoma cells. Mechanistically, fisetin activates PKCα, leading to phosphorylation and degradation of β-catenin, thereby downregulating MITF expression. Additionally, it activates ERK and AKT/GSK3β pathways, promoting ubiquitination and proteasomal degradation of MITF, resulting in reduced levels of tyrosinase, TRP-1, and TRP-2. The proteasome inhibitor MG132 confirmed that fisetin accelerates β-catenin and MITF degradation. Additionally, inhibition of the PI3K/AKT pathway by LY294002 or the ERK pathway by PD98059 reversed fisetin's reduction of tyrosinase activity and melanin synthesis, further verifying the participation of these pathways. Computational docking integrated with deep learning-based CNN scoring revealed that fisetin interacts with PKCα, β-catenin, tyrosinase, and TYRP1. Collectively, these findings suggest that fisetin exerts multi-targeted inhibitory effects on melanogenesis, highlighting its potential as a therapeutic and cosmetic agent for hyperpigmentation.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms262311739
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Zin, Z., Racha, S., Zou, H., & B, P.C. (2025). Mechanistic Insights into Anti-Melanogenic Effects of Fisetin: PKCα-Induced β-Catenin Degradation, ERK/MITF Inhibition, and Direct Tyrosinase Suppression. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms262311739
Vancouver
Zin Z, Racha S, Zou H, B PC. Mechanistic Insights into Anti-Melanogenic Effects of Fisetin: PKCα-Induced β-Catenin Degradation, ERK/MITF Inhibition, and Direct Tyrosinase Suppression. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311739.
BibTeX
@article{zin2025Mechan,
title = {Mechanistic Insights into Anti-Melanogenic Effects of Fisetin: PKCα-Induced β-Catenin Degradation, ERK/MITF Inhibition, and Direct Tyrosinase Suppression},
author = {Zin Zin and Satapat Racha and Hongbin Zou and Pithi Chanvorachote B},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262311739},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nutrients 2020
Open access · CC-BY
Nicotinamide Riboside—The Current State of Research and Therapeutic Uses
International Journal of Molecular Sciences 2019
Open access · CC-BY
Combined Treatment with L-Carnitine and Nicotinamide Riboside Improves Hepatic Metabolism and Attenuates Obesity and Liver Steatosis
Frontiers in Pharmacology 2025
Open access · CC-BY
Targeting natural antioxidant polyphenols to protect neuroinflammation and neurodegenerative diseases: a comprehensive review
Annals of Medicine 2011
Open access · OA
Sirtuin 1 in lipid metabolism and obesity
Medical Science Monitor 2011
Open access · CC-BY
SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease
Current Nutrition Reports 2023
Open access · OA